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ABSTRACT A membrane bilayer pathway model has been proposed for the interaction of dihydropyridine (DHP)
calcium channel antagonists with receptors in cardiac sarcolemma (Rhodes, D. G., J. G. Sarmiento, and L. G. Herbette.
1985. Mol. Pharmacol. 27:612-623) involving drug partition into the bilayer with subsequent receptor binding
mediated (though probably not rate-limited) by diffusion within the bilayer. Recently, we have characterized the
partition step, demonstrating that DHPs reside, on a time-average basis, near the bilayer hydrocarbon core/water
interface. Drug distribution about this interface may define a plane of local concentration for lateral diffusion within the
membrane. The studies presented herein examine the diffusional dynamics of an active rhodamine-labeled DHP and a
fluorescent phospholipid analogue (DiIC,6) in pure cardiac sarcolemmal lipid multibilayer preparations as a function of
bilayer hydration. At maximal bilayer hydration, the drug diffuses over macroscopic distances within the bilayer at a
rate identical to that of DiI (D = 3.8 x 10- cm2/s), demonstrating the overall feasibility of the membrane diffusion
model. The diffusion coefficients for both drug and lipid decreased substantially as the bilayers were dehydrated. While
identical at maximal hydration, drug diffusion was significantly slower than that of DiuC,6 in partially dehydrated
bilayers, probably reflecting differences in mass distribution of these probes in the bilayer.
INTRODUCTION
1 ,4-Dihydropyridine (DHP) calcium channel antagonists
inhibit channel opening of voltage-dependent calcium
channels in cardiac sarcolemma and a variety of other
membranes (Janis and Triggle, 1984; Hess et al., 1984).
The specific binding of these drugs to this membrane
receptor has been shown by Belleman and co-workers
(1983) to be highly stereoselective, saturable, and revers-
ible (with Kd values ranging from 0.2 to 3.0 nM in cardiac
membranes [Janis and Triggle, 1984]).1 A second low
affinity binding site with a Kd of 30-100 nM has also been
identified in cardiac sarcolemma (Janis and Triggle,
1984). Receptor-ligand stereoselectivity is highlighted by
structure/activity relationships observed for various DHP
analogues as well as the demonstration of both positive and
negative inotropic activities associated with enantiomeric
DHP pairs, e.g., Sandoz 202, 791 and PN 200, 110 (Hof et
al., 1985; Kongsamut et al., 1985; Langs and Triggle,
1985).
Send all correspondence to David W. Chester, Ph.D., Department of
Medicine, University of Connecticut Health Center, Farmington, CT
06032.
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submitted for publication.
Recently, Rhodes and co-workers (1985) proposed that
a two-step mechanism, the "membrane bilayer pathway"
model, is involved in DHP receptor binding. This mem-
brane model (M) involving drug partition and orientation
within the membrane and lateral diffusion within a plane
of the bilayer on approach to their specific receptor is in
contrast to the "aqueous pathway" model (A) involving
random diffusion through the bulk water phase and subse-
quent receptor interaction at an exposed site (see Fig. 1).
Theoretical calculations for diffusion-limited rates for
drug binding demonstrate the membrane pathway to be
some three orders of magnitude faster than the aqueous
pathway (Rhodes et al., 1985).
Several lines of evidence support the concept of the
membrane pathway being operable for the interaction of
DHP calcium channel antagonists (and possibly agonists)
with their receptors. Membrane partition coefficients for
several DHPs range from Kp of 5,000 to 150,000 (Herbette
et al., 1985, 1986). We have also determined the time-
averaged position of these drugs at the hydrocarbon core/
water interface in both native and model membrane sys-
tems." 2 Moreover, nimodipine has been shown, by neutron
2Chester, D. W., S. D. Wang, and L. G. Herbette, manuscript in
preparation.
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diffraction studies, to diffuse ("flip-flop") between the
monolayers of the membrane bilayer (Herbette, 1986).
The ability to diffuse through the membrane is consistent
with recent studies by Affolter and Coronado (1985, 1986)
demonstrating that both DHP (Bay K 8644) and phenylal-
kylamines (D-600) readily cross the bilayer to interact
with asymmetrically reconstituted calcium channels in a
planar lipid bilayer system.
Several physical characteristics of cardiac sarcolemmal
membranes (CSL) are also in support of this notion.
Because of low receptor site density in CSL membranes
(Colvin et al., 1985), two-dimensional diffusion through
the bilayer can lead to a significant rate advantage in the
diffusion-limited case (McCloskey and Poo, 1986), but
only if the ligand can assume the required position and
orientation within the bilayer needed for proper interaction
with the receptor binding site. Low receptor site density in
these membranes is coincident with a relatively high
lipid/protein ratio (3,000 nM/mg protein; Colvin et al.,
1985), high receptor binding affinities (Janis and Scria-
bine, 1983), and intrinsic "on rates" for specific binding of
0.6-1 x I07(ms) 'reported by Herbette et al.'
The multipoint analysis fluorescence recovery after pho-
tobleaching (FRAP) technique described by Koppel
(1979) has been used to further our analysis of the
membrane bilayer pathway model by measurement of the
lateral diffusion coefficient (D) of a fluorescently labeled
DHP (nisoldipine-lissamine rhodamine [Ns-R]) in cardiac
sarcolemmal lipid multibilayers. Such measurements serve
two fundamental purposes. First, they put the analysis of
the bilayer pathway model on a firmer quantitative basis.
Measured values of D put upper limits to the possible
values of drug binding rates obtained in a diffusion-limited
case. Furthermore, even if binding rates prove not to be
diffusion limited (and thus, not particularly sensitive to
diffusion rates), the relative values of D obtained in these
experiments, compared with those of other well character-
FIGURE 1 Schematic diagram of
the possible pathways by which an
amphiphilic or lipophilic drug could
reach its receptor site: a single step
aqueous pathway (A) or a two-step
membrane pathway (M). According
to the membrane pathway, a drug
may enter the bulk lipid phase on the
side of the membrane to which it was
added and diffuse laterally to a
hydrophobic (left side) or hydro-
philic (right side) binding site. Alter-
) natively, a drug could diffuse or flip-
flop across the bilayer with some
characteristic rate to gain access to
the opposite side of the membrane.
(Reproduced from Mol. Pharma-
col, 1985, 27:612-623, by copyright
permission of the American Society
for Pharmacology and Experimental
Therapeutics.)
ized fluorescent probes in the same membrane system,
provide a critical assay of the nature of the interaction of
these probes with the membrane bilayer. These studies,
therefore, constitute an initial approach directed toward
determination of the microscopic rate constants associated
with DHP receptor binding. The multibilayer samples used
for these studies were prepared by a modification of the
spin-dry procedure described by Clark et al. (1980). This
procedure produces extended multilamellar membrane
samples and allows precise control over drug/lipid ratios
and relative bilayer hydration. Drug and phospholipid
analogue diffusion coefficients were found to be identical
at maximal bilayer hydration, but differ significantly at
lower hydration.
MATERIALS AND METHODS
Membrane Isolation and Lipid Preparation
Crude canine cardiac sarcolemmal membranes were isolated by the
method of Jones et al. (1980). Lipids were extracted from these CSL
preparations essentially by the method of Folch et al. (1957). Polar and
neutral lipid composition was analyzed by thin layer chromatography
(TLC) on 250-um silica gel 60 TLC plates (EM Reagents, Merck,
Darmstadt, FRG) by developing -15 cm in a single dimension with
chloroform/methanol/20% methylamine/water (60:36:10:0.3, vol/vol)
to resolve the polar lipids with subsequent development (20 cm) in the
same direction with benzene/diethylether/ethanol/28% ammonia
(50:40:2:0.1, vol/vol) to resolve the neutral lipids. For two-dimensional
TLC, chloroform/methanol/28% ammonia (65:35:5, vol/vol) was used
as the primary and chloroform/acetone/acetic acid/water (5:3:1:1:0.5,
vol/vol) as secondary solvent. The various lipid classes were visualized
under long wave UV light after the fluorescent spray reagent, 1 mM
2-p-toluidinyl-6-naphthalenesulfonate (TNS; Eastman Kodak Co.,
Rochester, NY) in 50 mM Tris/HCl pH 7.5, was applied to the plates.
Lipid class composition was assessed by scanning TNS fluorescence with
a model SL-2DUV soft laser scanning densiotometer (Zeineh Biomedical
Instruments, Inc., Fullerton, CA) or scraping of bands for lipid phosphate
analysis. For preparative purposes, polar lipids and endogenous choles-
terol were separated from contaminating neutral lipids (triglycerides,
cholesterol esters, etc.) by developing the plates in benzene/diethylether/
ethanol/28% ammonia (50:40:2:0.1, vol/vol), which resolves all the
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neutral lipids while leaving the polar lipids at the origin. Cholesterol and
polar lipid bands were identified with distilled water, scraped, eluted with
chloroform/methanol (1:1, saturated with water), and dried on a rotary
evaporator and resuspended in chloroform/methanol (19:1, saturated
with water). Trace amounts of silica and non-lipid contaminants were
removed by elution of the lipid preparation from a 10 x 0.5-cm Sephadex
G-25 column equilibrated in methanol/water (1:1, vol/vol) and pre-run
with chloroform/methanol (19:1, vol/vol, water saturated) just before
fractionation. The phospholipid and cholesterol class composition was
examined and compared against profiles before purification and the lipids
stored under N2 at - 200C.
Lipid phosphorus was determined by a modification of the method of
Chen et al. (1956). Briefly, 50 gl of 72% perchloric acid is added to 1-40
nmol of phospholipid phosphorus (solvents dried off) in borosilicate tubes
and hydrolyzed for 1 h at 1800C in a sand block heater. The following
reagents were prepared for the phosphomolybdate complex color develop-
ment: solution A, 1.58% ascorbate (prepared fresh daily); solution B, 5.09
g ammonium molybdate, 33 ml concentrated H2SO4, and 84 ml distilled
water; solution C, 21.0 ml reagent A, 2.0 ml reagent B. Reagent C (0.9
ml) is added to the cooled perchloric acid digest, color developed at 80QC
for 15 min, and absorbance determined at 820 nm. Unexposed silica was
used as a blank for phosphate analysis off the TLC plate.
All organic solvents were redistilled before use.
Synthesis of the
(2-N-Sulfonamidolissamine
rhodamine)ethyl
methyl-2,6-dimethyl-4-(2-nitrophenyl)- 1,4-
dihydropyridine-3,5-dicarboxylate
Fluorescent DHP Probe
Full details of the synthetic methodology will be published separately. In
brief, to (2-aminoethyl) methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-
3,5-dicarboxylate (0.68 g, 0.001 mol) in 10 ml of methanol containing
0.15 ml triethylamine was added dropwise lissamine rhodamine sulfo-
nylchloride (0.25 g, 0.0004 mol; Molecular Probes, Inc., Junction City,
OR) dissolved in 25 ml acetone. The reaction stood overnight, was
concentrated in vacuo, diluted with 200 ml methylene chloride, and the
organic layer washed with 100 ml of 5% hydrochloric acid and aliquots of
water totaling 2,500 ml. The washed organic layer was then dried and
concentrated to a deep red oil that crystallized from ethanol. The
fluorescent DHP was examined for purity by TLC yielding Rf values of
0.5 and 0.44 after developing in ethanol (ETOH) or ethyl acetate/
ETOH/chloroform (30:25:15, vol/vol), respectively. Yield was 0.036 g,
melting point 217-2200C, and spectral assignments (infrared, nuclear
magnetic resonance) were in accord with the structural assignment.
Specific Nitrendipine Displacement Studies
with Ns-R
Ns-R displacement of specifically bound [3H}nitrendipine (New England
Nuclear, Boston, MA; specific activity 85 Ci/mmol) to a microsomal
fraction of guinea pig ileal longitudinal smooth muscle was determined
according to our previously established methods (Bolger et al., 1983).
Multilamellar Vesicle Preparation
Multilamellar vesicles were prepared in the presence or absence of known
amounts of fluorescent probe essentially by the method of Bangham et al.
(1965). CSL lipids were dried as a thin film on glass tubes under N2 and
residual solvent removed en vacuo (<10I m vacuum) for 2-4 h. A
specified volume of 0.5 mM Hepes, pH 7.27, 2 mM NaCl containing
Ns-R was added to the dried lipid preparation yielding a final lipid
phosphorus concentration of 3.62 ,M/ml and drug/lipid ratios ranging
from 1:1-03 to 1:105 (3.62 nM/ml-36.2 pM/ml). The l,1'-dihexadecyl-
3,3,3',3'-tetramethylindocarbanocyanine (DiIC16) probe (Molecular
Probes Inc.) used for the determination of phospholipid diffusion coeffi-
cients in this study was co-dried with the lipid with a constant probe/lipid
ratio of 1:104. Multilamellar vesicles were prepared and equilibrated with
the drug (or DiIC16) overnight at 4°C before formation of multilayers (see
below).
Preparation of Multibilayer Samples for
FRAP and X-ray Diffraction
The spin dry technique of Clark et al. (1980) has been adapted to our
specific needs. This procedure takes advantage of the centrifuge vacuum
for dehydration of the membrane sample during centrifugation producing
highly ordered multibilayer pellets. Precise control can be exerted over
drug (or probe)/lipid ratios since these ratios can be preset during vesicle
preparation. Further, in excess of 95% of the added lipid phosphate is
typically recovered in the membrane pellet. Quantitative and reproduc-
ible recovery is important for these FRAP studies as well as diffraction
studies to determine bilayer drug location which use similar sample
preparation conditions (Trumbore, M., D. W. Chester, and L. G.
Herbette, manuscript submitted for publication).
The major modification to the Clark et al. (1980) spin dry method
involves the use of lucite sedimentation cells (University of Pennsylvania
Biomedical Instrumentation Shop; design previously described by Her-
bette et al., 1977) which provide a flat surface onto which the membranes
may be pelleted. These cells, routinely used for diffraction sample
preparation, are adapted to fit the rotor SW-28 series (Beckman Instru-
ments Inc., Palo Alto, CA). A second set of caps to these rotor buckets
(spin dry caps), for use during the spin dry process, have been tapped with
a 1-mm hole which is overlaid with a mylar window containing a 100-Mgm
diam hole. The size and condition of each hole is readily assessed and
cleaned (with a microsyringe wire, <100-,gm diam) on a dissecting
microscope. For multibilayer sample formation, 50,Ml of the multilamellar
vesicle preparation described above was added to the sedimentation cells
with either a nonfluorescent Aclar (Dacron; Allied Chemical Corp.,
Morristown, NJ) or aluminum foil substrate used respectively for either
FRAP or diffraction measurements. The vesicles were sedimented onto
the substrate at 85,000 g for 30 min in an SW-28 rotor. The normal
bucket caps were then replaced with the spin dry caps and the pelleted
vesicles spin dried at 65,000 g for 5 h. On completion of the spin dry
process, the samples were mounted and rehydrated over saturated salt
solutions for FRAP and diffraction methods as described below.
Salt solutions used for the various humidities were as follows:
Mg(NO3)2, 55%; NaNO2, 66%; (NH4)2SO4, 81%; KCl, 88%; ZnSO4,
93%; K2SO4, 98%.
Microscopy
Light photomicroscopy was performed on a photomicroscope (Zeiss,
Oberkochen, FRG) equipped with Nomarski differential interference
contrast optics. For transmission electron microscopy, the multilayer
samples were exposed to 2% OS04 vapor for 5-10 min at 40C. On
completion of fixation, the samples were maintained in a humidified
atmosphere until processed for embedment and sectioning. Thin sections
were cut, stained for 15 min in 2% uranyl acetate, and viewed on a Hitachi
II electron microscope.
Diffraction
In the diffraction studies, the multilayer samples were mounted on a
curved glass support and rehydrated initially over saturated NaNO2 (66%
relative humidity) at 40C. The curved multilayer specimens were exposed
at 1 50C to a collimated, monochromatic x-ray beam (Cuk.,, x-rays,
X = 1.54 A) from a rotating anode x-ray generator (Rigaku Co. Dencki,
Ltd., Tokyo, Japan). The experimental method uses a single Franks'
mirror defining a line source where K 1 and K,,2 are unresolved. The data
were recorded on Kodak DEF-5 film. These studies were performed over
the same humidity range used in FRAP measurements as a means of
verifying changes in the unit cell repeat as a function of bilayer
hydration.
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Fluorescence Analyses
FRAP measurements of DiIC16 (phospholipid) and Ns-R diffusion
coefficients were performed with an excitation wavelength of 5,145 A on
an Ortholux II fluorescence microscope (E. Leitz, Inc., Rockleigh, NJ)
equipped with a vertical illuminator, water-cooled argon laser light source
(Cooper LaserSonics, Fremont, CA), and a galvanometric scanning
mirror. The basic design and geometry of the optical system has been
previously described (Koppel, 1979). For these studies, it was determined
empirically that 180 nM of phospholipid phosphorus should yield a pellet
lO-1Am thick. The pellet thickness is of strong consideration in these
photobleaching experiments as it is important that the bleach/monitoring
beam be focused at the multibilayer sample plane. Under these condi-
tions, sufficient fluorescence signal is detected from the 180-1.8 pmol of
drug (Ns-R) used to obtain the desired range of drug/lipid ratios (1:103 to
105). The multibilayer samples were rehydrated over a well (plexiglass/
glass slide assembly) containing a small bead of saturated salt solution
defining a relative humidity range from 55 to 98% (see above for details).
All FRAP studies were carried out at 21.5°C. Samples were maintained
at 40C during equilibration intervals between analyses. The initially
uniform sample fluorescence was locally depleted (or bleached) by short
(40 ms) exposure to a laser beam focused by a IOx objective to a small,
circularly symmetric spot. The fluorescence redistribution after photo-
bleaching was followed with a series of 12-point scans with an attenuated
monitoring beam.
The percent recovery and recovery rate were determined with a three
parameter nonlinear least squares analysis of the time decay of the
fluorescence depletion monitored coincident with the position of the
bleaching pulse. To determine the bleach spot size, w, used to calculate
the diffusion coefficients from recovery rates, the immediate post-bleach
intensity profile was reconstructed (by empirically extrapolating the
fluorescence traces measured at each position back to time zero) and fit to
an assumed Gaussian profile (Koppel, 1979).
RESULTS
Characterization of Multibilayer Samples
Used in FRAP Experiments
The class composition of the CSL lipid preparation used in
these studies is provided in Fig. 2 highlighting the phos-
pholipid class heterogeneity of the cardiac sarcolemma.
CSL lipids were chosen for these studies since they repre-
sent those associated with the DHP receptor in the native
membrane and, as such, more closely represent the recep-
tor environment. The sterol present in this preparation is
endogenous and represents - 13% of the total lipid consis-
tent with previously reported values (Colvin et al., 1985).
All of the non-bilayer neutral lipid contaminants (trigly-
cerides, cholesterolesters, etc.) have been removed by the
TLC purification procedure. In the lipid profile shown in
Fig. 2, one unidentified band (?) is consistently present in
these lipid preparations. Since the CSL lipids were
extracted from a crude preparation of cardiac sarcolemma,
contaminating membrane subfractions could be responsi-
ble for this additional band. Interestingly, while it appears
to be a major component as indicated by TNS fluorescence
intensity, no phosphate is associated with this band.
Multibilayer sample integrity for FRAP studies was
prescreened light microscopically to assess the gross mor-
phological characteristics of the pellets at the various
degrees of bilayer hydration. Characteristic multilayer
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FIGURE 2 Cardiac sarcolemmal lipid class composition. (a) The lipids
were developed as described in Materials and Methods and charred with
3% cupric acetate, 8% phosphoric acid, and compared against known
phospholipid standards. The percent phospholipid phosphate, as deter-
mined for each band by phosphate assay off TLC plate, is also indicated. b
represents fluorescence scans of the phospholipid profile before (----) and
after (-) TNS staining to illustrate bands of autofluorescent (----)
intensity. For the purpose of comparison, the auto- and TNS fluorescence
scans are scaled to approximately equivalent intensity.
samples at several relative humidities appear to be textu-
rally uniform (Fig. 3). This uniformity is maintained for
the experimental life of the sample and does not differ
significantly for different bilayer hydration states. There is
some surface contour to the multilayer (Fig. 3 C) consis-
tent with trans-axial fluorescence scans of the pellets (data
not shown), indicating long-range fluorescence intensity
differences. The local sample uniformity was monitored in
the normal course of each FRAP experiment (see upper
scan stacks in Fig. 5 A). Typically, 10 equally spaced
scanning positions, covering a scan length of 18 ,um, are
centered about the bleached spot and flanked on either side
by two additional positions separated by 100 ,tm. The
outermost points provide useful control data sensitive to
systematic drifts such as probe bleaching during monitor-
ing.
The extent of multilamellar vesicle fusion into extended
multibilayer sheets was observed as shown in Fig. 4. In Fig.
4 A, a multilamellar vesicle can be seen with the outer
leaflets contiguous with the adjacent membrane stacks
while the inner leaflets do not appear to have fused. In
these samples, relatively few vesicle ends can be identified,
indicating that the in-plane probe diffusion would not be
limited by poor vesicle fusion. This is demonstrated by
nearly complete fluorescence recovery after the photo-
bleaching event (see Fig. 5). Fig. 4 B represents a multi-
layer that was fixed in a near maximal hydrated state (98%
relative humidity). While maintaining the multilamellar
structure, the sample appears to be more swollen than
samples fixed at 81% relative humidity (Fig. 4 A) in
agreement with the x-ray diffraction data.
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AFIGURE 3 Nomarski photomicrographs of multilayers hydrated to (A)
66%, (B) 81%, and (C) 88% relative humidity to illustrate the relative
uniformity of the multibilayer pellets. 364x.
FIGURE 4 Transmission electron micrographs of thin sections cut per-
pendicular to the multibilayer plane. Samples were fixed with 2% OS04
vapor in an atmosphere of (A) 81% and (B) 98% relative humidity.
312,000x.
X-ray diffraction studies were performed in parallel
with the FRAP experiments to verify the changes in
multilayer unit cell repeat as a function of relative bilayer
hydration. These studies demonstrated that the multilayers
were well ordered, as indicated by low mosaic spread, and
swelled (increase in the average multilayer unit cell repeat)
as the bilayers were hydrated. These findings are consis-
tent with both light and electron microscope observations,
demonstrating the reasonable uniformity of these samples.
Low resolution profile structures generated from these
diffraction data demonstrated that the phosphate-to-phos-
phate distance across the bilayer remains constant (39 A)
CHESTER ET AL. Diffusion of Dihydropyridine Ca Channel Antagonists 1025
Ac f.
II
x( fim)
0 t(SI
while unit cell repeats increased from 53.4 to 61.5 A over
the humidity range of 66 to 93%.
The data presented above suggest that the multilayers
produced by the spin dry technique are very well suited for
the determination of fluorescent drug and phospholipid
diffusion coefficients by the FRAP method. Moreover,
these studies can be performed at very low, non-bilayer
perturbing probe/lipid ratios.
Fluorescence
Before FRAP analysis of drug (probe) diffusional
dynamics, the multibilayers were examined for sample and
substrate (aclar) autofluorescence in the absence of added
fluorophore. The fluorescence intensity associated with the
aclar was very low in comparison with other substrates
examined (plastic or mylar). This autofluorescence was
bleached with the laser bleach pulse but failed to recover
during the time frame used in these studies. The sample
autofluorescence intensity was somewhat greater than that
associated with the aclar substrate and did recover upon
bleaching. A diffusion coefficient of 1.37 x 10-1 cm2/s, at
81% relative humidity, was calculated which is similar to
phospholipid values obtained with DiIC16.
The origin of the sample autofluorescence was examined
and determined to be associated with the isolated phos-
pholipids. Fig. 2 b represents fluorescence scans of TLC-
separated phospholipids before and after TNS staining.
The association of this fluorescence with the phospholipid
was maintained in two-dimensional TLC, using two dif-
ferent solvent system schemes. Moreover, when examined
at high concentration in chloroform, these lipids elicited
broad excitation and emission spectra with maxima at
-4,000 and 5,250 A, respectively. The fluorescence inten-
sity at 5,500 A, the cut-off of the dichroic mirror and
barrier filters, is -44% that observed at the emissions
maximum. In any experiment, this autofluorescence inten-
sity contributed <5% of the total intensity obtained from
either Ns-R or the DiIC16 at 1:104 probe/lipid ratios and,
FIGURE 5 Typical FRAP data ob-
tained for DiIC16 at 55% relative
humidity. (A) Stack of 84 individual
twelve point scans through the
bleached area, highlighting the flat
pre-bleach intensity and return to
-
__TVWFWVWWWW this profile after a 40-ms bleach
pulse (dip in scan profile). (B)
Linear sequence of all the data dur-
ing the series of fluorescence scans.
(C) Fluorescence depletion coinci-
dent with the bleach point. Solid line
30* is a three-parameter least squares fit
of the data presented in B.
as such, does not impact on the fluorescence signal used in
the determination of diffusion coefficients.
The FRAP data obtained for Ns-R and DiIC16 at
probe-to-lipid ratios of 1: I04 are presented in Figs. 5-7. To
obtain an accurate assessment of both the diffusion coeffi-
cient, D, and percent recovery, the overall time of data
collection was varied such that half maximal recovery was
observed after 10-20 of the total of 75 post-bleach scans.
Fig. 5 is a display of one set of data obtained from the
DiIC,6 probe at 55% relative humidity. Fig. 5 B is a linear
sequence of all the data during the series of fluorescence
scans with a focused laser beam. In Fig. 5 A, the same data
are presented as a stack of 84 individual 12 point scans
recorded at 4.8-s intervals before and after bleaching. Fig.
5 C shows the fluorescence depletion coincident with the
position of the bleaching pulse as a function of the time
after bleaching. The solid line is a three-parameter least
squares fit to the data corresponding to an extrapolated
fluorescence recovery (i.e., mobile fraction) of 98%.
Distinct changes in the diffusion coefficients for both the
drug and DiIC16 were observed as a result of alterations in
relative bilayer hydration (Figs. 6 and 7). Fig. 6 illustrates
the least squares fit of the recovery data for Ns-R and
DiIC16 at 55 (Fig. 6 A) and 98% (Fig. 6 B) relative
humidity. Note the time scales and the fact that the
diffusion rates increase 50- and 200-fold for DiIC16 and
Ns-R, respectively, as bilayer hydration was increased
from 55 to 98%. Moreover, there was a fourfold difference
in diffusion coefficient between Ns-R and DiIC16 at 55%
while no difference was apparent at 98% relative humidity.
The relationship of drug and lipid diffusion coefficients as
a function of relative bilayer hydration is shown in Fig. 7.
From the FRAP data obtained in this study, the Ns-R
DHP drug analogue, which is active as a calcium channel
antagonist (Table I), has a diffusion coefficient of 3.8 x
l0o cm2/s at maximal bilayer hydration. This value is
identical with that obtained for phospholipids under identi-
cal conditions. Moreover, diffusion coefficients were simi-
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FIGURE 6 Decay of fluorescence depletion coincident with the bleach
point for Ns-R (0) and DiIC16 (A) at (A) 55% and (B) 98% relative
humidity. The solid and dashed lines represent three-parameter least
squares fits of the data.
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FIGURE 7 Diffusion coefficient, D, as a function of relative bilayer
hydration. These average values and error bars (standard deviation) were
determined from a minimum of five sets of data. The relative bilayer
hydration of the samples was maintained by equilibration over saturated
salt solutions which define a specific water vapor pressure (range
55-98%).
TABLE I
PERCENT INHIBITION OF SPECIFIC [3H]NITRENDIPINE
(5 x 10" M) BINDING IN GUINEA PIG ILLIUM
SMOOTH MUSCLE MEMBRANES BY THE
NISOLDIPINE-RHODAMINE ANALOGUES AS A
FUNCTION OF METHYLENE SEGMENT LENGTH
Percent inhibition
Conc.
I II III
M
10-'° 0.00 (5)
io-9 1.6 ± 0.6 (4)* 24.8 ± 11.7 (3)
10- 18.2 ± 7.3 (4) 27.5 ± 17.6 (5) 61.9 ± 16.9 (4)
10-, 54.8 ± 8.6 (4) 71.0 ± 10.4 (5) 90.0 ± 3.6 (4)
10-6 92.0 ± (1) - 87.4 ± 4.5 (4)
Probe I, n = 2; probe II, n = 6; probe III, n= 11.
*Refers to the number of experimental values collected.
lar for Ns-R concentrations ranging from 1:103 to 1:104,
indicating that there are no concentration effects at these
probe-to-lipid ratios on drug diffusional dynamics in these
membranes. Despite the similarities in probe diffusion at
complete bilayer hydration, it is interesting to note the
substantial differences in diffusional dynamics as bilayer
hydration is decreased. As discussed below, this may
reflect some differences in the relative locations of these
two probes within the bilayer.
DISCUSSION
Depending upon the pathway, specific binding of DHP to
receptors in sarcolemmal membranes, in general, will be
governed by such parameters as the rate of ligand diffu-
sion, drug orientation/conformation required for active
site binding, ligand concentration at the binding site,
binding constraints imposed by receptor state, etc. Addi-
tionally, the rate of bilayer partition and subsequent effects
on drug orientation/conformation must be considered
when dealing with ligands that bind at receptor sites within
the membrane. Rhodes and co-workers (1985) and Her-
bette et al. (1985) have proposed the membrane bilayer
pathway for drug-receptor interaction (see Fig. 1), which
provides an appropriate mechanism for optimizing drug
orientation/conformation, thereby maximizing the overall
rate for the receptor binding process. The theoretical
diffusion-limited rate for this pathway was calculated to be
some three orders of magnitude faster than that attainable
directly via an aqueous route. A two-step binding mecha-
nism is supported by the time-averaged location ofDHP at
the hydrocarbon core/water interface."2 Moreover, the
theoretical rate analyses presented by Rhodes et al. (1985)
suggest that despite strong ligand anisotropy, the receptor-
ligand interaction is not diffusion limited. As such, dis-
crimination between the two pathways, aqueous and mem-
brane, requires a thorough investigation of the microscopic
rate constants associated with each step in the receptor
binding process. Receptor binding kinetic analyses will also
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provide some important information relative to the rate-
limiting step in the overall mechanism.
The structure/activity relationships cited by Bolger et
al. (1983) and Janis and Scriabine (1983) are indicative of
the conformational and orientational requirements for
receptor binding. This is further demonstrated with enan-
tiomeric DHP pairs (e.g., 202,791) where the isomers
possess either agonist or antagonistic activity with the
agonist activity strongly dependent upon membrane poten-
tial (Kongsamut et al., 1985; Hof et al., 1985). This
delicate balance of structure and activity is also demon-
strated by an interesting feature of the fluorescent DHP
analogue used in this study where the methylene segment
length between the rhodamine and DHP strongly affects
the ability of this ligand to displace nitrendipine from the
DHP receptor (see Table I). It would appear that the
observed activity differences are not related to minor
differences in diffusion coefficient since, as concluded by
Rhodes et al. (1985), receptor binding does not appear to
be diffusion limited. Moreover, preliminary diffusion data
with probe I (n = 2) yield a similar diffusion coefficient to
that of Ns-R (probe III) at low bilayer hydration (66%),
suggesting that the activity differences are related to
alterations in ligand orientation or depth of penetration
into the membrane.
Structure studies reveal the location of the DHP at the
hydrocarbon core/water interface."2 In the context of
bilayer location, this region is the most constrained due to
phospholipid packing and related surface tension. This
location, on a time-averaged basis, would potentially define
a concentration gradient centered about this interface
within which DHP could diffuse. It is not unreasonable to
anticipate that this locale could also correspond with that
portion of the receptor protein containing the binding
domain. The hydrocarbon core/water interface provides
an interesting physical chemical environment for ligands
such as DHP. As stated earlier, the properties of this
interface would impose, for the sake of minimum energy,
conformational and orientational constraints on the ligand
as it diffuses along the interface to interact with the
receptor. A close correlation between the time-averaged
DHP location and receptor binding domain within the
bilayer could begin to suggest a mechanism for voltage
potential-dependent activity of these ligands involving con-
figurational shifts in the binding domain affecting the
interaction with ligand in a specific equilibrium minimum
energy conformation.
In this study, we have begun to examine the diffusion
limits for DHP in pure cardiac sarcolemmal lipid bilayers
as an initial approach to understanding the diffusional
dynamics of these drugs in native cardiac membranes. We
have determined that the diffusion coefficient of an active
DHP analogue (see Table I), Ns-R, is 3.8 x 10-8 cm2/s,
the same as that obtained for phospholipids under identical
conditions. The diffusion coefficients observed here are
similar to those obtained for NBD-labeled phospholipid by
McCowen et al. (1981) and those determined by an
independent method using the rate of pyrene eximer
formation (Eisinger and Halperin, 1986). Rapid bilayer
partition rates, indicated by the rate of nonspecific bind-
ing,1 and rapid diffusion within the bilayer are processes
that are significantly faster than the overall binding to the
receptor, suggesting that these events "set up" the appro-
priate equilibrium conditions for drug binding to the
receptor.
Reducing bilayer hydration has profound effects on the
diffusion of both Ns-R and DiIC16, as illustrated in Figs. 6
and 7. The changes in diffusion coefficient that we have
observed are qualitatively similar to that reported by
McCowen et al. (1981) in a different lipid system, though
considerably greater in magnitude over the same range of
relative humidity. The differential decrease of Ns-R diffu-
sion relative to DiIC16 diffusion is of considerable interest
to us and, as such, we are continuing to explore this
phenomenon with other membrane probes. This differen-
tial effect is likely to be a reflection of different bilayer
positions for these two probes, as illustrated in Fig. 8. The
charged rhodamine moiety of the DHP analogue would be
expected to extend further from the bilayer hydrophobic
domain, interacting more strongly with the phospholipid
headgroup region. This rhodamine position is supported by
studies conducted by Loew and co-workers (1986), demon-
strating that certain charged rhodamines (e.g., rhodamine
123) do not penetrate membrane bilayers and hence,
remain outside the bilayer hydrophobic domain. This
contention is also supported by some recent data (to be
published) demonstrating that free rhodamine diffusion
between bilayers under identical conditions is by far less
constrained relative to the DHP-chromophore complex or
phospholipids. It is anticipated that DiIC16, on the other
hand, would be embedded deeper into the bilayer. The
general decrease of diffusivity with decreased hydration
may reflect either surface condensation, interbilayer head-
group interactions, or some combination of the two, as
discussed by McCowen et al. (1981). Differential diffusion
changes can also be explained in the context of the free
volume model of diffusion (Vaz et al., 1985). Surface
condensation, decreasing the availability of free volume
spaces for diffusional jumps, would preferentially slow
down those probe molecules with the larger cross-sectional
dimension at some critical plane within the bilayer. From
the vantage point of the data presented herein, the relative
locations, bilayer interactions at that locale, chromophore
squatness, etc. may also play a role in defining the diffu-
sional dynamics of small molecules in membranes.
SUMMARY
We have recently determined that two DHP analogues,
nimodipine and Bay P 8857, are located near to the
hydrocarbon core/water interface (Herbette et al., 1985).2
This location is similar to that obtained for the amphipha-
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specific binding and activity of these ligands, once they
have diffused to and reside at the protein receptor site.
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